Philips Showcases Tele-Ultrasound at AIUM Virtual Event

Royal Philips announced its participation in the upcoming Annual Integrative Ultrasound Meeting (AIUM) virtual event, April 11-14, hosted by the American Institute of Ultrasound in Medicine.

FUJIFILM Healthcare starts to operate as Fujifilm Group company

Adding CT/MRI and other medical devices to the lineup to globally provide value-added solutions based on medical IT

Hyperfine Launches ‘Total Rethink Buying Process’

Hyperfine Research announced in a press release that it is pioneering a wholesale simplification of the capital equipment purchasing experience with the launch of its Total Rethink Buying Process.

Cardinal Health Launches Navista TS

Cardinal Health Specialty Solutions has launched Cardinal Health Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve outcomes and costs associated with patient treatment as they transition to value-based care.

Tempus Unveils Tempus ONE

Tempus Unveils Tempus ONE

Tempus recently unveiled a new technology for oncologists in Tempus ONE. This smart, voice-enabled, portable device brings Tempus’ proprietary platform and library of multi-modal data to life, offering physicians real-time access to all the clinical insights and data contained in Tempus’ genomic reports in the palm of their hand. In beta currently and launching more broadly in 2021, Tempus ONE is the first step toward bringing the full power of artificial intelligence to the point-of-care.

Tempus’ multi-omic molecular tests arm oncologists with their patients’ actionable genetic alterations, and the company’s proprietary platform connects that data to phenotypic and morphologic patient data, including longitudinally updated outcome data from electronic health records (EHR), to provide clinical context to every test. To alleviate the amount of time clinicians must spend on their computers, Tempus has designed ONE as a portable device with the ability to relay all of the information contained in its reports, along with vast amounts of relevant additional data regarding that patient, in real-time, seamlessly integrating into their existing workflow. The handheld, cube-like device takes questions and input from physicians through an embedded microphone array and produces a response for playback through its proprietary voice-activated speaker system specifically designed with physicians’ needs in mind.

“For the past 5 years we have been on a journey to bring the promise and power of artificial intelligence to health care,” said Eric Lefkofsky, founder and CEO of Tempus. “Tempus ONE is a quantum leap forward, harnessing the almost 30 petabytes of data we have collected in the past few years, which we embedded into a device that fits in the palm of your hand and puts the full breadth and scope of our technology platform in the hands of every doctor we serve, enhancing their ability to use data in making real-time treatment decisions.”

“Tempus created a learning health care system at massive scale that gains intelligence and insights with each stream of data and interaction,” says Joel Dudley, chief scientific officer of Tempus. “Tempus ONE enables clinicians to interact with vast Tempus information resources as they would interact with other members of their care team. At the same time, every question and conversation posed to Tempus ONE improves our ability to deliver the highest-quality information and insights to the next patient case.”

Tempus ONE is in beta release and will only be made available to selected oncologists during the pre-launch phase. For more information, visit



Submit a Comment

Your email address will not be published. Required fields are marked *